TRACC
11 Nov 2020
Trial Summary
An Australian, non-interventional registry to evaluate clinical outcomes and bevacizumab use in metastatic colorectal cancer from routine clinical practise.
Acronym:
TRACC
ACTRN/NCT /ethics:
N/A
Scientific title:
An Australian, non-interventional registry to evaluate clinical outcomes and bevacizumab use in metastatic colorectal cancer from routine clinical practise.
Sponsor / Cooperative group:
N/A
Trial & Patient Characteristics
| Cancer Type | Bowel and colon |
|---|---|
| Trial Type | Early detection, diagnosis, prognosis |
| Phase | All phases |
| Age Range | 18 years and older |
| Sex | Both |
| Tumour Stream | colorectal |
| Cancer Stage | Metastatic or Widespread |
| Anticipated Start Date | N/A |
| Anticipated End Date | N/A |
Participating Hospitals
| Hospital | The Queen Elizabeth Hospital |
|---|---|
| Clinical Trial Coordinator | Pamela Cooper |
| pamela.cooper@sa.gov.au | |
| Phone | 08 8222 6140 |
| Principal Investigator | Professor Tim Price |
| Recruitment Status | Not Yet Recruiting |